News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
206,722 Results
Type
Article (8701)
Company Profile (17)
Press Release (198001)
Multimedia
Podcasts (13)
Webinars (8)
Section
Business (78378)
Career Advice (458)
Deals (11425)
Drug Delivery (23)
Drug Development (22781)
Employer Resources (53)
FDA (4388)
Job Trends (4239)
News (116233)
Policy (8466)
Tag
Academia (706)
Accelerated approval (8)
Adcomms (12)
Allergies (38)
Alliances (13351)
ALS (39)
Alzheimer's disease (522)
Antibody-drug conjugate (ADC) (95)
Approvals (4533)
Artificial intelligence (144)
Autoimmune disease (28)
Automation (6)
Bankruptcy (73)
Best Places to Work (3583)
BIOSECURE Act (3)
Biosimilars (48)
Biotechnology (8)
Bladder cancer (32)
Brain cancer (9)
Breast cancer (145)
Cancer (1413)
Cardiovascular disease (90)
Career advice (389)
Career pathing (10)
CAR-T (55)
CDC (5)
Celiac Disease (1)
Cell therapy (166)
Cervical cancer (13)
Clinical research (20093)
Collaboration (449)
Compensation (54)
Complete response letters (8)
COVID-19 (608)
CRISPR (19)
C-suite (250)
Cystic fibrosis (30)
Data (1913)
Decentralized trials (1)
Denatured (6)
Depression (13)
Diabetes (128)
Diagnostics (2108)
Digital health (10)
Diversity (1)
Diversity, equity & inclusion (15)
Drug discovery (60)
Drug pricing (25)
Drug shortages (2)
Duchenne muscular dystrophy (40)
Earnings (46220)
Editorial (9)
Employer branding (8)
Employer resources (49)
Events (29183)
Executive appointments (281)
FDA (5289)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (1)
Frontotemporal dementia (5)
Funding (272)
Gene editing (37)
Generative AI (15)
Gene therapy (120)
GLP-1 (174)
Government (1027)
Grass and pollen (2)
Guidances (246)
Healthcare (5373)
HIV (43)
Huntington's disease (6)
IgA nephropathy (20)
Immunology and inflammation (44)
Immuno-oncology (16)
Indications (39)
Infectious disease (685)
Inflammatory bowel disease (50)
Influenza (26)
Intellectual property (78)
Interviews (67)
IPO (5774)
IRA (3)
Job creations (832)
Job search strategy (353)
JPM (11)
Kidney cancer (10)
Labor market (10)
Layoffs (91)
Leadership (8)
Legal (1604)
Liver cancer (23)
Longevity (2)
Lung cancer (242)
Lymphoma (141)
Machine learning (13)
Management (20)
Manufacturing (190)
MASH (27)
Medical device (4414)
Medtech (4435)
Mergers & acquisitions (5902)
Metabolic disorders (262)
Multiple sclerosis (48)
Neurodegenerative disease (85)
Neuropsychiatric disorders (9)
Neuroscience (828)
NextGen: Class of 2026 (1621)
Non-profit (1230)
Now hiring (5)
Obesity (114)
Opinion (54)
Ovarian cancer (39)
Pain (32)
Pancreatic cancer (58)
Parkinson's disease (103)
Partnered (7)
Patents (120)
Patient recruitment (109)
Peanut (22)
People (19480)
Pharmaceutical (9)
Pharmacy benefit managers (1)
Phase 1 (5395)
Phase 2 (8528)
Phase 3 (7600)
Pipeline (1835)
Policy (40)
Postmarket research (818)
Preclinical (2207)
Press Release (12)
Prostate cancer (78)
Psychedelics (4)
Radiopharmaceuticals (92)
Rare diseases (172)
Real estate (1528)
Recruiting (21)
Regulatory (6971)
Reports (9)
Research institute (681)
Resumes & cover letters (64)
Rett syndrome (6)
RSV (21)
Schizophrenia (44)
Series A (48)
Series B (32)
Service/supplier (1)
Sickle cell disease (20)
Spinal muscular atrophy (29)
Sponsored (13)
Startups (791)
Stomach cancer (5)
Supply chain (21)
Tariffs (16)
The Weekly (7)
Vaccines (246)
Venture capital (17)
Weight loss (50)
Women's health (17)
Worklife (5)
Date
Last 7 days (160)
Last 30 days (563)
Last 365 days (8428)
2026 (718)
2025 (8474)
2024 (9891)
2023 (11877)
2022 (15696)
2021 (16962)
2020 (16256)
2019 (13921)
2018 (10665)
2017 (10914)
2016 (9898)
2015 (12215)
2014 (8658)
2013 (6708)
2012 (7350)
2011 (7880)
2010 (6914)
Location
Africa (266)
Alabama (10)
Arizona (52)
Arkansas (1)
Asia (15346)
Australia (2729)
California (2755)
Canada (966)
China (452)
Colorado (135)
Connecticut (97)
Delaware (80)
Europe (33611)
Florida (468)
Georgia (97)
Hawaii (2)
Idaho (23)
Illinois (235)
India (21)
Indiana (159)
Iowa (3)
Japan (174)
Kansas (26)
Kentucky (11)
Louisiana (16)
Maine (51)
Maryland (334)
Massachusetts (1892)
Michigan (105)
Minnesota (181)
Missouri (43)
Montana (12)
Nebraska (7)
Nevada (41)
New Hampshire (28)
New Jersey (1030)
New Mexico (5)
New York (731)
North Carolina (413)
North Dakota (2)
Northern California (1292)
Ohio (76)
Oklahoma (5)
Oregon (7)
Pennsylvania (586)
Puerto Rico (6)
Rhode Island (7)
South America (443)
South Carolina (23)
Southern California (1192)
Tennessee (26)
Texas (359)
United States (10233)
Utah (95)
Virginia (35)
Washington D.C. (14)
Washington State (223)
West Virginia (1)
Wisconsin (34)
Wyoming (2)
206,722 Results for "eps international".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Press release: 2025: strong sales and EPS growth. Continued profitable growth expected in 2026
January 29, 2026
·
3 min read
Press Releases
McKesson Corporation Reports Fiscal 2026 Third Quarter Results and Raises Full Year Adjusted EPS Guidance
February 5, 2026
·
1 min read
Press Releases
Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance
December 17, 2025
·
19 min read
Press Releases
Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance
November 5, 2025
·
19 min read
Press Releases
Vektor Medical to Showcase VITAL-EP Registry’s Atrial Fibrillation Results, Including Fast, Zero-Fluoro PVI+ Ablation Workflow, and New Atrial Flutter Capabilities
February 5, 2026
·
4 min read
Press Releases
EpiEndo Pharmaceutical’s ERJ Open Research article reports first clinical trial of glasmacinal (EP395) in COPD patients
December 8, 2025
·
3 min read
Press Releases
Corning Announces Third-Quarter 2025 Financial Results(1) with Record Core Sales and Core EPS
October 28, 2025
·
13 min read
Press Releases
Biorem Reports Record Order Backlog, - $11.3 Million of Revenues in the Quarter and Quarterly EPS of $0.07
November 18, 2025
·
3 min read
Press Releases
Henry Schein Reports Record Third Quarter 2025 Financial Results and Raises Full Year Non-GAAP EPS Guidance
November 5, 2025
·
19 min read
Press Releases
Foghorn Therapeutics Announces Updates for Selective ARID1B, Selective CBP and Selective EP300 Degrader Programs
October 31, 2025
·
6 min read
1 of 20,673
Next
